期刊文献+

艾滋病合并机会性感染的临床特征和诊疗分析 被引量:22

Analysis on Clinical Features of Acquired Immune Deficiency Syndrome Combined with Opportunistic Infections and Its Diagnosis and Treatment
原文传递
导出
摘要 目的探讨艾滋病患者合并机会性感染的临床特征并评价其治疗效果。方法回顾分析2003年2009年53例确诊为艾滋病患者的临床资料,对患者合并机会性感染的临床特征,包括发生机会性感染的时间、发生机会性感染时CD4+T细胞计数、起病急缓、严重程度等,进行观察和分析,并给予国家推荐的标准治疗方案进行治疗,通过临床症状、病毒载量、CD4+T细胞计数、影像学监测进行疗效分析,随访时间为初治至出院后6年。结果 53例艾滋病患者均为重症感染,41例为混合感染,其中2个以上部位感染者为36例(67.9%),2种以上病原体感染者为28例(52.8%),3种以上病原体感染者13例(24.5%)。最常见的机会性感染为结核35.8%(19/53);其次为卡氏肺孢子菌肺炎30.2%(16/53);败血症20.8%(11/53),此外,尚有隐球菌感染15.1%(8/53)、弓形虫感染3.8%(2/53)、带状疱疹病毒感染7.5%(4/53)、念珠菌感染17.0%(9/53)、巨细胞病毒感染7.5%(4/53)、合并乙肝11.3%(6/53)、丙肝3.8%(2/53)。机会性感染治疗有效率为77.4%(41/53),病死率为22.6%(12/53),其中隐球菌脑膜炎或混合感染者病死率最高。结论艾滋病患者在CD4+T细胞计数<350/mm3时各种机会感染明显升高,且随着CD4+T细胞计数的下降呈增高趋势,艾滋病合并机会性感染最常见的是结核,其次卡氏肺孢子菌肺炎;合并结核的治疗效果较好,合并隐球菌脑病的病死率最高。早期启动高效抗逆转录病毒治疗效果好。 Objective To investigate the clinical characteristics of acquired immune deficiency syndrome(AIDS) combined with opportunistic infections and its treatment.Methods We retrospectively analyzed the clinical data of 53 patients diagnosed to have AIDS in our hospital between 2003 and 2009.The clinical features(such as time of the onset of opportunistic infections,CD+4 T cells value at the onset,severity of the infection,etc.) of the opportunistic infections(such as tuberculosis,Pneumocystis carinii pneumonia,toxoplasmosis,etc.) were also observed and analyzed.The patients were treated according to the national standards.The clinical outcome was analyzed based on such indicators as clinical symptoms,viral load,CD+4 T cells value at the onset,and the results of various imaging.Follow-up was done for six years.Results All 53 patients had severe AIDS infection.Forty-one of them had combined infections,among whom 36(67.9%) had infections in two or more parts of the body,28(52.8%) were infected by two or more pathogens,and 13(24.5%) were infected by three or more pathogens.The most common opportunistic infection was tuberculosis(35.8%,19/53) followed by pneumocystis carinii pneumonia(30.2%,16/53) and septicemia(20.8%,11/53).Other infections included cryptococcal infection(15.1%,8/53),toxoplasma gondii infection(3.8%,2/53),herpes zoster virus infection(7.5%,4/53),candidiasis(17.0%,9/53),cytomegalovirus infection(7.5%,4/53),combined hepatitis B(11.3%,6/53),and hepatitis C(3.8%,2/53).Effective treatment rate for opportunistic infections was 77.4%(41/53) with a mortality of 22.6%(12/53).The highest fatality rate occurred to those patients with cryptococcal meningitis or mixed infections.Conclusions The occurrence of opportunistic infections rises obviously when CD+4 T cells is lower than 350/mm3,and it increases more significantly as the value of CD4+ T cells goes down.The most common opportunistic infection is tuberculosis followed by pneumocystis carinii pneumonia.The clinical outcome for the combined cases of tuberculosis is good,while combined cryptococcal encephalopathy has the highest mortality rate.High active anti-retroviral therapy should be initiated as early as possible.
出处 《华西医学》 CAS 2011年第10期1496-1500,共5页 West China Medical Journal
关键词 艾滋病 机会性感染 高效抗逆转录病毒治疗 疗效 Acquired immune deficiency syndrome Opportunistic infection High active anti-retroviral therapy Clinical efficacy
  • 相关文献

参考文献17

  • 1王爱霞,王福生,王清玥,王健,冯铁建,卢洪洲,孙洪清,孙永涛,叶寒辉,李太生,李兴旺,刘正印,邢玉兰,何云,汪宁,吴昊,吴南屏,张福杰,周曾全,宫恩聪,赵红心,赵敏,唐小平,徐莲芝,徐小元,曹韵贞,康来仪,蒋岩,蔡卫平,樊庆泊,潘孝彰.艾滋病诊疗指南[J].中华传染病杂志,2006,24(2):133-144. 被引量:634
  • 2国家免费艾滋病抗病毒药物治疗手册编写组.国家免费艾滋病抗病毒药物治疗手册[M]2版.北京:人民卫生出版社,2008.42-107.
  • 3World Health Organization. Guidelines for the clinical management of HIV infections in adults [J]. Geneva: WHO/ GPA, 1991:2.
  • 4Esteves F, Gaspar J, Marques T. Identification of relevant single-nucleotide polymorphisms in Pneumocystis j irovecii: relationship with clinical data[J]. Clin Microbiol Infect, 2010, 16(7) : 878-884.
  • 5Lu JJ, Lee CH. Pneumocystis pneumonia[J]. J Formos ivied Assoc, 2008, 107(11):830-842.
  • 6Fujisawa T, Suda T, Matsuda H. Real-time PCR is more specific than conventional PCR for induced sputum diagnosis of Pneumocystis pneumonia in immunocompromised patients without HIV infection[J]. Respirology 2009, 14(2), 203-209.
  • 7Nakamura H, Tateyama M, Tasato D, et al. Clinical utility of serum beta-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia[J]. Intern Med, 2009, 48(4): 195-202.
  • 8Watanabe T, Yasuoka A, Tanuma J, et al. Serum beta D glucan as a noninvasive adjunct marker for the diagnosis of Pneumocystis pneumonia in patients with AIDS[J]. Clin Infect Dis, 2009, 49(7): 1128-1131.
  • 9陈仕晓,毛碧容,胡晓中,朱帆,周瑞锋.85例AIDS并机会感染患者的临床分析[J].华西医学,2009,24(1):171-173. 被引量:6
  • 10张彤,吴昊,张可,徐连芝,孙桂珍.艾滋病患者死亡原因分析[J].首都医科大学学报,2002,23(2):148-150. 被引量:26

二级参考文献20

  • 1王永怡.对艾滋病现状谈几点感触[J].传染病信息,2007,20(2):122-124. 被引量:5
  • 2李在村,吴昊.HIV/AIDS患者贫血的研究进展[J].国外医学(流行病学.传染病学分册),2004,31(6):351-353. 被引量:23
  • 3郜桂菊,张福杰,姚均,赵红心,卢联合,李鑫.HIV感染者/AIDS患者CD_4^+细胞计数与机会性感染对应关系的临床分析[J].中国艾滋病性病,2005,11(4):241-243. 被引量:87
  • 4曹韵贞.抗逆转录病毒治疗方法的新进展[J].中国艾滋病性病,2005,11(6):464-467. 被引量:12
  • 5编写组.国家免费艾滋病抗病毒药物治疗手册[M].北京:人民卫生出版社,2005:74.
  • 6Pillay D,Taylor S,Richman DD.Incidence and impact of re sistance against approved antiretroviral drugs.Rev Med Virol,2000,10:231-253.
  • 7Susman E.Many HIV patients carry mutated drug-resistant strains.Lancet,2002,359:49.
  • 8Little SJ,Holte S,Routy JP,et al.Antiretroviral-drug resistance among patients recently infected with HIV.N Engl J Med,2002,347:385-394.
  • 9Whitcomb JM,Parkin NT,Chappey C,et al.Broad nucleoside reverse transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates.J Infect Dis,2003,188:992-1000.
  • 10Calvez V,Costagliola D,Descamps D,et al.Impact of stavu dine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial.Antivir Ther,2002,7:211-218.

共引文献720

同被引文献175

引证文献22

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部